APA (7th ed.) Citation

Y, W., Y, Z., C, S., J, L., & X, H. (2024). Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women. Risk Management and Healthcare Policy, ume 17, 1669-1685.

Chicago Style (17th ed.) Citation

Y, Wang, Zhao Y, Shi C, Li J, and Huang X. "Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women." Risk Management and Healthcare Policy ume 17 (2024): 1669-1685.

MLA (9th ed.) Citation

Y, Wang, et al. "Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women." Risk Management and Healthcare Policy, vol. ume 17, 2024, pp. 1669-1685.